RIO DE JANEIRO, Dec 30 (Reuters) - AstraZeneca said on
Wednesday it is working efficiently and transparently to bring
its vaccine to Brazil as fast as possible, adding that it
remains committed to seeking full regulatory approval in Brazil
after authorization in the UK.
In a statement, AstraZeneca said it would keep up the
ongoing submission of its late-stage trial results, but made no
mention of seeking emergency use approval — a process that
Pfizer has described as cumbersome in Brazil.
(Reporting by Eduardo Simoes
Editing by Chizu Nomiyama)